© 2026 GlobalCapital, Derivia Intelligence Limited, company number 15235970, 161 Farringdon Rd, London EC1R 3AL. All rights reserved.

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement | Event Participant Terms & Conditions | Cookies

Equity

More articles

More articles

More articles

  • Goldman Sachs placed HK$5.43bn ($700m) worth of borrowed stock in China Pacific Insurance Group Co (CPIC) on March 18, the public leg of a derivative agreement with Allianz through which the German insurer hedged part of its stake in the Chinese firm.
  • Two pharmaceutical companies are preparing to list their shares on the Hong Kong Stock Exchange, with PuraPharm Corp and Zhongzhi Pharmaceutical Holdings filing their respective preliminary prospectuses on March 18.
  • India’s Adlabs Entertainment wrapped up its extended IPO this week, raising Rp3.70bn ($59m) by pricing its shares at the bottom of a revised range.
  • Korea Deposit Insurance Corp (KDIC) shed some of its shares in Hanwha Life Insurance Co via a block executed on the evening of March 18. Launched to the market with a fixed price, the W133.4bn ($118m) deal focused more on size than on price.
  • At least three Chinese brokerages are readying Hong Kong IPOs for the first half of the year, while two more will launch chunky H-share placements soon. The trades should be well received as investors have cash to spare, but the yawning gap in valuations between A and H-shares and a surfeit of offerings from the sector mean that issuers and underwriters will need to relent on pricing, writes John Loh.
  • Haitong International Securities Group is gunning for a capital raising of up to HK$9.10bn ($1.17bn) via a one-for-one rights issue, with 65% shareholder, Haitong International Holdings Limited (HTIH), committing to take up its entire rights entitlement to provide early momentum for the trade.
shared comment list